201 related articles for article (PubMed ID: 30854542)
1. The effect of an interprofessional pain service on nonmalignant pain control.
Coffey CP; Ulbrich TR; Baughman K; Awad MH
Am J Health Syst Pharm; 2019 May; 76(Supplement_2):S49-S54. PubMed ID: 30854542
[TBL] [Abstract][Full Text] [Related]
2. Impact of a pharmacist-directed pain management service on inpatient opioid use, pain control, and patient safety.
Poirier RH; Brown CS; Baggenstos YT; Walden SG; Gann NY; Patty CM; Sandoval RA; McNulty JR
Am J Health Syst Pharm; 2019 Jan; 76(1):17-25. PubMed ID: 31381097
[TBL] [Abstract][Full Text] [Related]
3. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
[TBL] [Abstract][Full Text] [Related]
4. Team-Based Medicine: Incorporating a Clinical Pharmacist into Pain and Opioid Practice Management.
Boren LL; Locke AM; Friedman AS; Blackmore CC; Woolf R
PM R; 2019 Nov; 11(11):1170-1177. PubMed ID: 30729723
[TBL] [Abstract][Full Text] [Related]
5. Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety.
Cox N; Tak CR; Cochella SE; Leishman E; Gunning K
J Am Board Fam Med; 2018; 31(1):105-112. PubMed ID: 29330245
[TBL] [Abstract][Full Text] [Related]
6. Clinical Pharmacy Services in a Multidisciplinary Specialty Pain Clinic.
Semerjian M; Durham MJ; Mirzaian E; Lou M; Richeimer SH
Pain Pract; 2019 Mar; 19(3):303-309. PubMed ID: 30403432
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a pharmacist-managed clinic for patients with chronic nonmalignant pain.
Norman JL; Kroehl ME; Lam HM; Lewis CL; Mitchell CN; O'Bryant CL; Trinkley KE
Am J Health Syst Pharm; 2017 Aug; 74(16):1229-1235. PubMed ID: 28790075
[TBL] [Abstract][Full Text] [Related]
9. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a community based nurse-pharmacist managed pain clinic: A mixed-methods study.
Hadi MA; Alldred DP; Briggs M; Marczewski K; Closs SJ
Int J Nurs Stud; 2016 Jan; 53():219-27. PubMed ID: 26384958
[TBL] [Abstract][Full Text] [Related]
11. A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial.
Cochran G; Chen Q; Field C; Seybert AL; Hruschak V; Jaber A; Gordon AJ; Tarter R
Drug Alcohol Depend; 2019 Dec; 205():107570. PubMed ID: 31689641
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice.
Ma JD; Tran V; Chan C; Mitchell WM; Atayee RS
J Oncol Pharm Pract; 2016 Dec; 22(6):757-765. PubMed ID: 26428283
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a Proactive Pilot Health Plan-Driven Opioid Tapering Program to Decrease Chronic Opioid Use for Conditions of the Back and Spine in a Medicaid Population.
Page J; Traver R; Patel S; Saliba C
J Manag Care Spec Pharm; 2018 Mar; 24(3):191-196. PubMed ID: 29485946
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a pharmacist-led service for patients at high risk for opioid overdose.
Tewell R; Edgerton L; Kyle E
Am J Health Syst Pharm; 2018 Mar; 75(6):376-383. PubMed ID: 29523534
[TBL] [Abstract][Full Text] [Related]
15. Implementing an opioid risk assessment telephone clinic: Outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.
Jacobs SC; Son EK; Tat C; Chiao P; Dulay M; Ludwig A
Subst Abus; 2016; 37(1):15-9. PubMed ID: 26675444
[TBL] [Abstract][Full Text] [Related]
16. Achieving blood pressure control among renal transplant recipients by integrating electronic health technology and clinical pharmacy services.
Migliozzi DR; Zullo AR; Collins C; Elsaid KA
Am J Health Syst Pharm; 2015 Nov; 72(22):1987-92. PubMed ID: 26541954
[TBL] [Abstract][Full Text] [Related]
17. Revealing undetected problems with medication therapy management services.
Alexander AJ; Gatewood SB
Consult Pharm; 2008 Jun; 23(6):473-6. PubMed ID: 18764677
[TBL] [Abstract][Full Text] [Related]
18. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to opioids for pain management in the emergency department decreases opioid usage and maintains patient satisfaction.
Duncan RW; Smith KL; Maguire M; Stader DE
Am J Emerg Med; 2019 Jan; 37(1):38-44. PubMed ID: 29709398
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a medication therapy management collaborative within a pediatric health system.
Sneed G; Kappeler K; Gilmore T; Kuhn C
J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
